A citation-based method for searching scientific literature

. Nature 2011
Times Cited: 4515



Junko Murai, Shar-yin N Huang, Benu Brata Das, Amelie Renaud, Yiping Zhang, James H Doroshow, Jiuping Ji, Shunichi Takeda, Yves Pommier. Cancer Res 2012
Times Cited: 945




List of shared articles



Times cited

Overcoming PARPi resistance: Preclinical and clinical evidence in ovarian cancer.
M Chiappa, F Guffanti, F Bertoni, I Colombo, G Damia. Drug Resist Updat 2021
0

Candidate Markers of Olaparib Response from Genomic Data Analyses of Human Cancer Cell Lines.
Setor Amuzu, Euridice Carmona, Anne-Marie Mes-Masson, Celia M T Greenwood, Patricia N Tonin, Jiannis Ragoussis. Cancers (Basel) 2021
0

C/EBPβ promotes poly(ADP-ribose) polymerase inhibitor resistance by enhancing homologous recombination repair in high-grade serous ovarian cancer.
Jiahong Tan, Xu Zheng, Mengchen Li, Fei Ye, Chunyan Song, Cheng Xu, Xiaoxue Zhang, Wenqian Li, Ya Wang, Shaoqing Zeng,[...]. Oncogene 2021
0

DNA replication stress and emerging prospects for PARG inhibitors in ovarian cancer therapy.
Nisha Pillay, Rosie M Brady, Malini Dey, Robert D Morgan, Stephen S Taylor. Prog Biophys Mol Biol 2021
1

The Synergistic Effect of PARP Inhibitors and Immune Checkpoint Inhibitors.
Zhaozhen Wu, Pengfei Cui, Haitao Tao, Sujie Zhang, Junxun Ma, Zhefeng Liu, Jinliang Wang, Yuanyu Qian, Shixue Chen, Ziwei Huang,[...]. Clin Med Insights Oncol 2021
2

Serine-linked PARP1 auto-modification controls PARP inhibitor response.
Evgeniia Prokhorova, Florian Zobel, Rebecca Smith, Siham Zentout, Ian Gibbs-Seymour, Kira Schützenhofer, Alessandra Peters, Joséphine Groslambert, Valentina Zorzini, Thomas Agnew,[...]. Nat Commun 2021
1

Targeting Non-Oncogene Addiction for Cancer Therapy.
Hae Ryung Chang, Eunyoung Jung, Soobin Cho, Young-Jun Jeon, Yonghwan Kim. Biomolecules 2021
0

Can integrative biomarker approaches improve prediction of platinum and PARP inhibitor response in ovarian cancer?
Ionut-Gabriel Funingana, Marika A V Reinius, Angelica Petrillo, Joo Ern Ang, James D Brenton. Semin Cancer Biol 2021
0